Gus Khursigara joined Inozyme Pharma in November 2019 and serves as the Vice President of Medical Affairs and Clinical Operations and has more than 15 years of experience in medical affairs and clinical development, which includes designing and executing global clinical trials.

Most recently, he was the Vice President, Global Medical Affairs, at Biohaven Pharmaceuticals, where he created the medical affairs department and supported the preparations for the company’s first commercial launch. Prior to Biohaven, he spent 12 years at Alexion Pharmaceuticals where he held roles of increasing responsibility, finishing his tenure as Vice President, Global Medical Affairs Lead, Neurology.

Dr. Khursigara earned a Ph.D. in molecular neuroscience from Cornell University, an MSc in physiology from the University of Connecticut, and a BA in biochemistry and cell biology from the University of California, San Diego.